Global and Japan Influenza Vaccines Market 2020 by Manufacturers, Type and Application, Forecast to 2025
Market Overview
The global Influenza Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.5% in the forecast period of 2020 to 2025 and will expected to reach USD 3889.8 million by 2025, from USD 3259.7 million in 2019.
The Influenza Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Influenza Vaccines market is split by Type and Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Breakdown by Type, Influenza Vaccines market has been segmented into Trivalent Flu Vaccines, Quadrivalent Flu Vaccines, etc.
Breakdown by Application, Influenza Vaccines has been segmented into Adults, Pediatrics, etc.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Influenza Vaccines market presented in the report. This section sheds light on the sales growth of different regional and country-level Influenza Vaccines markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Influenza Vaccines market.
For Japan, this report analyses the Japan market by players, Type and Application, for the period 2015-2025.
Competitive Landscape and Influenza Vaccines Market Share Analysis
Influenza Vaccines competitive landscape provides details by vendors, including company overview, company total revenue, market potential, global presence, Influenza Vaccines sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Influenza Vaccines sales, revenue and market share for each player covered in this report.
The major players covered in Influenza Vaccines are: AstraZeneca, FOLIA BIOTECH, Sanofi, CSL, FluGen, GlaxoSmithKline, Green Cross, BionVax, Altimmune, Genentech, SK Chemicals, Vaxart, Medicago, Visterra, UNM Pharma, Shijiazhuang Yiling Pharmaceutical, Moderna Therapeutics, Vaxine Pty, Vaccitech, Novavax, etc. Among other players domestic and global, Influenza Vaccines market share data is available for global, North America, Europe, Asia, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The key market players for global Influenza Vaccines market are listed below:
AstraZeneca
FOLIA BIOTECH
Sanofi
CSL
FluGen
GlaxoSmithKline
Green Cross
BionVax
Altimmune
Genentech
SK Chemicals
Vaxart
Medicago
Visterra
UNM Pharma
Shijiazhuang Yiling Pharmaceutical
Moderna Therapeutics
Vaxine Pty
Vaccitech
Novavax
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt and South Africa)
Market segment by Type, covers:
Trivalent Flu Vaccines
Quadrivalent Flu Vaccines
Market segment by Application, can be divided into
Adults
Pediatrics
Table of Contents
1 Market Overview
1.1 Influenza Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Influenza Vaccines Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Trivalent Flu Vaccines
1.2.3 Quadrivalent Flu Vaccines
1.3 Market Analysis by Application
1.3.1 Overview: Global Influenza Vaccines Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Adults
1.3.3 Pediatrics
1.4 Global Influenza Vaccines Market Size and Forecast (2015-2025)
1.4.1 Global Influenza Vaccines Revenue and Forecast (2015-2025)
1.4.2 Global Influenza Vaccines Sales and Forecast (2015-2025)
1.5 Global Influenza Vaccines Market Size Overview by Geography (2015-2020)
2 Manufacturers Profiles
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 AstraZeneca SWOT Analysis
2.1.4 AstraZeneca Product and Services
2.1.5 AstraZeneca Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 FOLIA BIOTECH
2.2.1 FOLIA BIOTECH Details
2.2.2 FOLIA BIOTECH Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 FOLIA BIOTECH SWOT Analysis
2.2.4 FOLIA BIOTECH Product and Services
2.2.5 FOLIA BIOTECH Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Sanofi SWOT Analysis
2.3.4 Sanofi Product and Services
2.3.5 Sanofi Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 CSL
2.4.1 CSL Details
2.4.2 CSL Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 CSL SWOT Analysis
2.4.4 CSL Product and Services
2.4.5 CSL Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 FluGen
2.5.1 FluGen Details
2.5.2 FluGen Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 FluGen SWOT Analysis
2.5.4 FluGen Product and Services
2.5.5 FluGen Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 GlaxoSmithKline
2.6.1 GlaxoSmithKline Details
2.6.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 GlaxoSmithKline SWOT Analysis
2.6.4 GlaxoSmithKline Product and Services
2.6.5 GlaxoSmithKline Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Green Cross
2.7.1 Green Cross Details
2.7.2 Green Cross Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Green Cross SWOT Analysis
2.7.4 Green Cross Product and Services
2.7.5 Green Cross Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 BionVax
2.8.1 BionVax Details
2.8.2 BionVax Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 BionVax SWOT Analysis
2.8.4 BionVax Product and Services
2.8.5 BionVax Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Altimmune
2.9.1 Altimmune Details
2.9.2 Altimmune Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Altimmune SWOT Analysis
2.9.4 Altimmune Product and Services
2.9.5 Altimmune Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Genentech
2.10.1 Genentech Details
2.10.2 Genentech Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Genentech SWOT Analysis
2.10.4 Genentech Product and Services
2.10.5 Genentech Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 SK Chemicals
2.11.1 SK Chemicals Details
2.11.2 SK Chemicals Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 SK Chemicals SWOT Analysis
2.11.4 SK Chemicals Product and Services
2.11.5 SK Chemicals Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Vaxart
2.12.1 Vaxart Details
2.12.2 Vaxart Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Vaxart SWOT Analysis
2.12.4 Vaxart Product and Services
2.12.5 Vaxart Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Medicago
2.13.1 Medicago Details
2.13.2 Medicago Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Medicago SWOT Analysis
2.13.4 Medicago Product and Services
2.13.5 Medicago Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Visterra
2.14.1 Visterra Details
2.14.2 Visterra Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Visterra SWOT Analysis
2.14.4 Visterra Product and Services
2.14.5 Visterra Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 UNM Pharma
2.15.1 UNM Pharma Details
2.15.2 UNM Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 UNM Pharma SWOT Analysis
2.15.4 UNM Pharma Product and Services
2.15.5 UNM Pharma Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 Shijiazhuang Yiling Pharmaceutical
2.16.1 Shijiazhuang Yiling Pharmaceutical Details
2.16.2 Shijiazhuang Yiling Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Shijiazhuang Yiling Pharmaceutical SWOT Analysis
2.16.4 Shijiazhuang Yiling Pharmaceutical Product and Services
2.16.5 Shijiazhuang Yiling Pharmaceutical Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 Moderna Therapeutics
2.17.1 Moderna Therapeutics Details
2.17.2 Moderna Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Moderna Therapeutics SWOT Analysis
2.17.4 Moderna Therapeutics Product and Services
2.17.5 Moderna Therapeutics Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.18 Vaxine Pty
2.18.1 Vaxine Pty Details
2.18.2 Vaxine Pty Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Vaxine Pty SWOT Analysis
2.18.4 Vaxine Pty Product and Services
2.18.5 Vaxine Pty Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.19 Vaccitech
2.19.1 Vaccitech Details
2.19.2 Vaccitech Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 Vaccitech SWOT Analysis
2.19.4 Vaccitech Product and Services
2.19.5 Vaccitech Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.20 Novavax
2.20.1 Novavax Details
2.20.2 Novavax Major Business and Total Revenue (Financial Highlights) Analysis
2.20.3 Novavax SWOT Analysis
2.20.4 Novavax Product and Services
2.20.5 Novavax Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Global Influenza Vaccines Market, Company Landscape
3.1 Company Market Share Analysis: Global
3.1.1 Global Influenza Vaccines Sales and Market Share by Manufacturer (2018-2019)
3.1.2 Global Influenza Vaccines Revenue and Market Share by Manufacturer (2018-2019)
3.2 Company Market Share Analysis: Japan
3.2.1 Key Players Influenza Vaccines Sales in Japan (2018-2019)
3.2.2 Japan Influenza Vaccines Revenue Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Influenza Vaccines Manufacturer Market Share in 2019
3.3.2 Top 6 Influenza Vaccines Manufacturer Market Share in 2019
4 Market Size by Geography
4.1 Global Influenza Vaccines Market Size by Geography (2015-2020)
4.1.1 Global Influenza Vaccines Sales by Geography (2015-2020)
4.1.2 Global Influenza Vaccines Revenue by Regions (2015-2020)
4.2 Global Influenza Vaccines Market Size and Forecast by Regions (2020-2025)
4.2.1 Global Influenza Vaccines Sales and Forecast by Regions (2020-2025)
4.2.2 Global Influenza Vaccines Revenue and Forecast by Regions (2020-2025)
4.3 North America Influenza Vaccines Market Size and Forecast (2015-2025)
4.4 Europe Influenza Vaccines Market Size and Forecast (2015-2025)
4.5 Asia-Pacific Influenza Vaccines Market Size and Forecast (2015-2025)
4.6 South America Influenza Vaccines Market Size and Forecast (2015-2025)
4.7 Middle East and Africa Influenza Vaccines Market Size and Forecast (2015-2025)
5 North America by Country
5.1 North America Influenza Vaccines Market Size by Country (2015-2020)
5.1.1 North America Influenza Vaccines Sales and Market Share by Country (2015-2020)
5.1.2 North America Influenza Vaccines Revenue and Market Share by Country (2015-2020)
5.2 North America Influenza Vaccines Market Size and Forecast by Country (2020-2025)
5.2.1 North America Influenza Vaccines Sales and Forecast by Country (2020-2025)
5.2.2 North America Influenza Vaccines Revenue and Forecast by Country (2020-2025)
5.3 United States Influenza Vaccines Market Size and Forecast (2015-2025)
5.4 Canada Influenza Vaccines Market Size and Forecast (2015-2025)
5.5 Mexico Influenza Vaccines Market Size and Forecast (2015-2025)
6 Europe by Country
6.1 Europe Influenza Vaccines Market Size by Country (2015-2020)
6.1.1 Europe Influenza Vaccines Sales by Country (2015-2020)
6.1.2 Europe Influenza Vaccines Revenue by Country (2015-2020)
6.2 Europe Influenza Vaccines Market Size and Forecast by Country (2020-2025)
6.2.1 Europe Influenza Vaccines Sales and Forecast by Country (2020-2025)
6.2.2 Europe Influenza Vaccines Revenue and Forecast by Country (2020-2025)
6.3 Germany Influenza Vaccines Market Size and Forecast (2015-2025)
6.4 United Kingdom Influenza Vaccines Market Size and Forecast (2015-2025)
6.5 France Influenza Vaccines Market Size and Forecast (2015-2025)
6.6 Russia Influenza Vaccines Market Size and Forecast (2015-2025)
6.7 Italy Influenza Vaccines Market Size and Forecast (2015-2025)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Influenza Vaccines Market Size by Region (2015-2020)
7.1.1 Asia-Pacific Influenza Vaccines Sales by Region (2015-2020)
7.1.2 Asia-Pacific Influenza Vaccines Revenue by Region (2015-2020)
7.2 Asia-Pacific Influenza Vaccines Market Size and Forecast by Region (2020-2025)
7.2.1 Asia-Pacific Influenza Vaccines Sales and Forecast by Region (2020-2025)
7.2.2 Asia-Pacific Influenza Vaccines Revenue and Forecast by Region (2020-2025)
7.3 China Influenza Vaccines Market Size and Forecast (2015-2025)
7.4 Japan Influenza Vaccines Market Size and Forecast (2015-2025)
7.5 Korea Influenza Vaccines Market Size and Forecast (2015-2025)
7.6 India Influenza Vaccines Market Size and Forecast (2015-2025)
7.7 Southeast Asia Influenza Vaccines Market Size and Forecast (2015-2025)
7.8 Australia Influenza Vaccines Market Size and Forecast (2015-2025)
8 South America by Country
8.1 South America Influenza Vaccines Market Size by Country (2015-2020)
8.1.1 South America Influenza Vaccines Sales by Country (2015-2020)
8.1.2 South America Influenza Vaccines Revenue by Country (2015-2020)
8.2 South America Influenza Vaccines Market Size and Forecast by Country (2020-2025)
8.2.1 South America Influenza Vaccines Sales and Forecast by Country (2020-2025)
8.2.2 South America Influenza Vaccines Revenue and Forecast by Country (2020-2025)
8.3 Brazil Influenza Vaccines Market Size and Forecast (2015-2025)
8.4 Argentina Influenza Vaccines Market Size and Forecast (2015-2025)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Influenza Vaccines Market Size by Country (2015-2020)
9.1.1 Middle East & Africa Influenza Vaccines Sales by Country (2015-2020)
9.1.2 Middle East & Africa Influenza Vaccines Revenue by Country (2015-2020)
9.2 Middle East & Africa Influenza Vaccines Market Size and Forecast by Country (2020-2025)
9.2.1 Middle East & Africa Influenza Vaccines Sales and Forecast by Country (2020-2025)
9.2.2 Middle East & Africa Influenza Vaccines Revenue and Forecast by Country (2020-2025)
9.3 Saudi Arabia Influenza Vaccines Market Size and Forecast (2015-2025)
9.4 Turkey Influenza Vaccines Market Size and Forecast (2015-2025)
9.5 Egypt Influenza Vaccines Market Size and Forecast (2015-2025)
9.6 South Africa Influenza Vaccines Market Size and Forecast (2015-2025)
10 Market Segment by Type
10.1 Global Influenza Vaccines Market Size by Type (2015-2020)
10.1.1 Global Influenza Vaccines Sales by Type (2015-2020)
10.1.2 Global Influenza Vaccines Revenue by Type (2015-2020)
10.1.3 Global Influenza Vaccines Price by Type (2015-2020)
10.2 Global Influenza Vaccines Market Size and Forecast by Type (2020-2025)
10.2.1 Global Influenza Vaccines Sales and Forecast by Type (2020-2025)
10.2.2 Global Influenza Vaccines Revenue and Forecast by Type (2020-2025)
10.2.3 Global Influenza Vaccines Price and Forecast by Type (2020-2025)
10.3 Japan Influenza Vaccines Market Size and Forecast by Type (2015-2025)
10.3.1 Japan Influenza Vaccines Market Size by Type (2015-2020)
10.3.2 Japan Influenza Vaccines Market Size and Forecast by Type (2020-2025)
11 Market Segment by Application
11.1 Global Influenza Vaccines Market Size by Application (2015-2020)
11.1.1 Global Influenza Vaccines Sales by Application (2015-2020)
11.1.2 Global Influenza Vaccines Revenue by Application (2015-2020)
11.1.3 Global Influenza Vaccines Price by Application (2015-2020)
11.2 Global Influenza Vaccines Market Size and Forecast by Application (2020-2025)
11.2.1 Global Influenza Vaccines Sales and Forecast by Application (2020-2025)
11.2.2 Global Influenza Vaccines Revenue and Forecast by Application (2020-2025)
11.2.3 Global Influenza Vaccines Price and Forecast by Application (2020-2025)
11.3 Japan Influenza Vaccines Market Size and Forecast by Application (2015-2025)
11.3.1 Japan Influenza Vaccines Market Size by Application (2015-2020)
11.3.2 Japan Influenza Vaccines Market Size and Forecast by Application (2020-2025)
12 Sales Channel, Distributors, Costumers, and Market Dynamics
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Distributors, Traders and Dealers
12.4.1 Market Opportunities
12.4.2 Market Risk
12.4.3 Market Driving Force
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Tables and Figures
List of Tables
Table 1. Global Influenza Vaccines Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Influenza Vaccines by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Influenza Vaccines Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Influenza Vaccines Market Size Overview by Geography (2015-2020) (USD Million)
Table 5. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 6. AstraZeneca Influenza Vaccines Major Business
Table 7. AstraZeneca Influenza Vaccines Total Revenue (USD Million) (2018-2019)
Table 8. AstraZeneca SWOT Analysis
Table 9. AstraZeneca Influenza Vaccines Product and Services
Table 10. AstraZeneca Influenza Vaccines Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 11. FOLIA BIOTECH Basic Information, Manufacturing Base and Competitors
Table 12. FOLIA BIOTECH Influenza Vaccines Major Business
Table 13. FOLIA BIOTECH Influenza Vaccines Total Revenue (USD Million) (2018-2019)
Table 14. FOLIA BIOTECH SWOT Analysis
Table 15. FOLIA BIOTECH Influenza Vaccines Product and Services
Table 16. FOLIA BIOTECH Influenza Vaccines Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 17. Sanofi Basic Information, Manufacturing Base and Competitors
Table 18. Sanofi Influenza Vaccines Major Business
Table 19. Sanofi Influenza Vaccines Total Revenue (USD Million) (2018-2019)
Table 20. Sanofi SWOT Analysis
Table 21. Sanofi Influenza Vaccines Product and Services
Table 22. Sanofi Influenza Vaccines Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 23. CSL Basic Information, Manufacturing Base and Competitors
Table 24. CSL Influenza Vaccines Major Business
Table 25. CSL Influenza Vaccines Total Revenue (USD Million) (2018-2019)
Table 26. CSL SWOT Analysis
Table 27. CSL Influenza Vaccines Product and Services
Table 28. CSL Influenza Vaccines Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 29. FluGen Basic Information, Manufacturing Base and Competitors
Table 30. FluGen Influenza Vaccines Major Business
Table 31. FluGen Influenza Vaccines Total Revenue (USD Million) (2018-2019)
Table 32. FluGen SWOT Analysis
Table 33. FluGen Influenza Vaccines Product and Services
Table 34. FluGen Influenza Vaccines Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 35. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 36. GlaxoSmithKline Influenza Vaccines Major Business
Table 37. GlaxoSmithKline Influenza Vaccines Total Revenue (USD Million) (2018-2019)
Table 38. GlaxoSmithKline SWOT Analysis
Table 39. GlaxoSmithKline Influenza Vaccines Product and Services
Table 40. GlaxoSmithKline Influenza Vaccines Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 41. Green Cross Basic Information, Manufacturing Base and Competitors
Table 42. Green Cross Influenza Vaccines Major Business
Table 43. Green Cross Influenza Vaccines Total Revenue (USD Million) (2018-2019)
Table 44. Green Cross SWOT Analysis
Table 45. Green Cross Influenza Vaccines Product and Services
Table 46. Green Cross Influenza Vaccines Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 47. BionVax Basic Information, Manufacturing Base and Competitors
Table 48. BionVax Influenza Vaccines Major Business
Table 49. BionVax Influenza Vaccines Total Revenue (USD Million) (2018-2019)
Table 50. BionVax SWOT Analysis
Table 51. BionVax Influenza Vaccines Product and Services
Table 52. BionVax Influenza Vaccines Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 53. Altimmune Basic Information, Manufacturing Base and Competitors
Table 54. Altimmune Influenza Vaccines Major Business
Table 55. Altimmune Influenza Vaccines Total Revenue (USD Million) (2018-2019)
Table 56. Altimmune SWOT Analysis
Table 57. Altimmune Influenza Vaccines Product and Services
Table 58. Altimmune Influenza Vaccines Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 59. Genentech Basic Information, Manufacturing Base and Competitors
Table 60. Genentech Influenza Vaccines Major Business
Table 61. Genentech Influenza Vaccines Total Revenue (USD Million) (2018-2019)
Table 62. Genentech SWOT Analysis
Table 63. Genentech Influenza Vaccines Product and Services
Table 64. Genentech Influenza Vaccines Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 65. SK Chemicals Basic Information, Manufacturing Base and Competitors
Table 66. SK Chemicals Influenza Vaccines Major Business
Table 67. SK Chemicals Influenza Vaccines Total Revenue (USD Million) (2018-2019)
Table 68. SK Chemicals SWOT Analysis
Table 69. SK Chemicals Influenza Vaccines Product and Services
Table 70. SK Chemicals Influenza Vaccines Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 71. Vaxart Basic Information, Manufacturing Base and Competitors
Table 72. Vaxart Influenza Vaccines Major Business
Table 73. Vaxart Influenza Vaccines Total Revenue (USD Million) (2018-2019)
Table 74. Vaxart SWOT Analysis
Table 75. Vaxart Influenza Vaccines Product and Services
Table 76. Vaxart Influenza Vaccines Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 77. Medicago Basic Information, Manufacturing Base and Competitors
Table 78. Medicago Influenza Vaccines Major Business
Table 79. Medicago Influenza Vaccines Total Revenue (USD Million) (2018-2019)
Table 80. Medicago SWOT Analysis
Table 81. Medicago Influenza Vaccines Product and Services
Table 82. Medicago Influenza Vaccines Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 83. Visterra Basic Information, Manufacturing Base and Competitors
Table 84. Visterra Influenza Vaccines Major Business
Table 85. Visterra Influenza Vaccines Total Revenue (USD Million) (2018-2019)
Table 86. Visterra SWOT Analysis
Table 87. Visterra Influenza Vaccines Product and Services
Table 88. Visterra Influenza Vaccines Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 89. UNM Pharma Basic Information, Manufacturing Base and Competitors
Table 90. UNM Pharma Influenza Vaccines Major Business
Table 91. UNM Pharma Influenza Vaccines Total Revenue (USD Million) (2018-2019)
Table 92. UNM Pharma SWOT Analysis
Table 93. UNM Pharma Influenza Vaccines Product and Services
Table 94. UNM Pharma Influenza Vaccines Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 95. Shijiazhuang Yiling Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 96. Shijiazhuang Yiling Pharmaceutical Influenza Vaccines Major Business
Table 97. Shijiazhuang Yiling Pharmaceutical Influenza Vaccines Total Revenue (USD Million) (2018-2019)
Table 98. Shijiazhuang Yiling Pharmaceutical SWOT Analysis
Table 99. Shijiazhuang Yiling Pharmaceutical Influenza Vaccines Product and Services
Table 100. Shijiazhuang Yiling Pharmaceutical Influenza Vaccines Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 101. Moderna Therapeutics Basic Information, Manufacturing Base and Competitors
Table 102. Moderna Therapeutics Influenza Vaccines Major Business
Table 103. Moderna Therapeutics Influenza Vaccines Total Revenue (USD Million) (2018-2019)
Table 104. Moderna Therapeutics SWOT Analysis
Table 105. Moderna Therapeutics Influenza Vaccines Product and Services
Table 106. Moderna Therapeutics Influenza Vaccines Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 107. Vaxine Pty Influenza Vaccines Type and Application
Table 108. Vaxine Pty Influenza Vaccines Major Business
Table 109. Vaxine Pty Influenza Vaccines Total Revenue (USD Million) (2018-2019)
Table 110. Vaxine Pty SWOT Analysis
Table 111. Vaxine Pty Influenza Vaccines Product and Services
Table 112. Vaxine Pty Influenza Vaccines Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 113. Vaccitech Basic Information, Manufacturing Base and Competitors
Table 114. Vaccitech Influenza Vaccines Major Business
Table 115. Vaccitech Influenza Vaccines Total Revenue (USD Million) (2018-2019)
Table 116. Vaccitech SWOT Analysis
Table 117. Vaccitech Influenza Vaccines Product and Services
Table 118. Vaccitech Influenza Vaccines Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 119. Novavax Basic Information, Manufacturing Base and Competitors
Table 120. Novavax Influenza Vaccines Major Business
Table 121. Novavax Influenza Vaccines Total Revenue (USD Million) (2018-2019)
Table 122. Novavax SWOT Analysis
Table 123. Novavax Influenza Vaccines Product and Services
Table 124. Novavax Influenza Vaccines Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 125. Global Influenza Vaccines Sales by Manufacturer (2018-2019) (K Units)
Table 126. Global Influenza Vaccines Revenue by Manufacturer (2018-2019) (USD Million)
Table 127. Key Players Influenza Vaccines Sales in Japan (2018-2019) (K Units)
Table 128. Key Players Influenza Vaccines Sales Market Share in Japan (2018-2019)
Table 129. Key Players Revenue of Influenza Vaccines in Japan (2018-2019) (USD Million)
Table 130. Global Influenza Vaccines Sales by Regions (2015-2020) (K Units)
Table 131. Global Influenza Vaccines Sales Market Share by Regions (2015-2020)
Table 132. Global Influenza Vaccines Revenue by Regions (2015-2020) (USD Million)
Table 133. Global Influenza Vaccines Sales and Forecast by Regions (2020-2025) (K Units)
Table 134. Global Influenza Vaccines Sales Market Share by Regions (2020-2025)
Table 135. Global Influenza Vaccines Revenue and Forecast by Regions (2020-2025) (USD Million)
Table 136. Global Influenza Vaccines Revenue Market Share by Regions (2020-2025) (USD Million)
Table 137. North America Influenza Vaccines Sales by Countries (2015-2020) (K Units)
Table 138. North America Influenza Vaccines Sales Market Share by Countries (2015-2020)
Table 139. North America Influenza Vaccines Revenue by Countries (2015-2020) (USD Million)
Table 140. North America Influenza Vaccines Revenue Market Share by Countries (2015-2020)
Table 141. North America Influenza Vaccines Sales by Country (2020-2025) (K Units)
Table 142. North America Influenza Vaccines Sales Market Share by Country (2020-2025)
Table 143. North America Influenza Vaccines Revenue by Country (2020-2025) (USD Million)
Table 144. North America Influenza Vaccines Revenue Market Share by Country (2020-2025)
Table 145. Europe Influenza Vaccines Sales by Countries (2015-2020) (K Units)
Table 146. Europe Influenza Vaccines Sales Market Share by Countries (2015-2020)
Table 147. Europe Influenza Vaccines Revenue by Countries (2015-2020) (USD Million)
Table 148. Europe Influenza Vaccines Revenue Market Share by Countries (2015-2020)
Table 149. Europe Influenza Vaccines Sales by Country (2020-2025) (K Units)
Table 150. Europe Influenza Vaccines Sales Market Share by Country (2020-2025)
Table 151. Europe Influenza Vaccines Revenue by Country (2020-2025) (USD Million)
Table 152. Europe Influenza Vaccines Revenue Market Share by Country (2020-2025)
Table 153. Asia-Pacific Influenza Vaccines Sales by Countries (2015-2020) (K Units)
Table 154. Asia-Pacific Influenza Vaccines Sales Market Share by Countries (2015-2020)
Table 155. Asia-Pacific Influenza Vaccines Revenue by Countries (2015-2020) (USD Million)
Table 156. Asia-Pacific Influenza Vaccines Revenue Market Share by Countries (2015-2020)
Table 157. Asia-Pacific Influenza Vaccines Sales by Country (2020-2025) (K Units)
Table 158. Asia-Pacific Influenza Vaccines Sales Market Share by Country (2020-2025)
Table 159. Asia-Pacific Influenza Vaccines Revenue by Country (2020-2025) (USD Million)
Table 160. Asia-Pacific Influenza Vaccines Revenue Market Share by Country (2020-2025)
Table 161. South America Influenza Vaccines Sales by Countries (2015-2020) (K Units)
Table 162. South America Influenza Vaccines Sales Market Share by Countries (2015-2020)
Table 163. South America Influenza Vaccines Revenue by Countries (2015-2020) (USD Million)
Table 164. South America Influenza Vaccines Revenue Market Share by Countries (2015-2020)
Table 165. South America Influenza Vaccines Sales by Country (2020-2025) (K Units)
Table 166. South America Influenza Vaccines Sales Market Share by Country (2020-2025)
Table 167. South America Influenza Vaccines Revenue by Country (2020-2025) (USD Million)
Table 168. South America Influenza Vaccines Revenue Market Share by Country (2020-2025)
Table 169. Middle East & Africa Influenza Vaccines Sales by Countries (2015-2020) (K Units)
Table 170. Middle East & Africa Influenza Vaccines Sales Market Share by Countries (2015-2020)
Table 171. Middle East & Africa Influenza Vaccines Revenue by Countries (2015-2020) (USD Million)
Table 172. Middle East & Africa Influenza Vaccines Revenue Market Share by Countries (2015-2020)
Table 173. Middle East & Africa Influenza Vaccines Sales by Country (2020-2025) (K Units)
Table 174. Middle East & Africa Influenza Vaccines Sales Market Share by Country (2020-2025)
Table 175. Middle East & Africa Influenza Vaccines Revenue by Country (2020-2025) (USD Million)
Table 176. Middle East & Africa Influenza Vaccines Revenue Market Share by Country (2020-2025)
Table 177. Japan Influenza Vaccines Sales by Type (2015-2020) (K Units)
Table 178. Japan Influenza Vaccines Sales Market Share by Type (2015-2020)
Table 179. Japan Influenza Vaccines Revenue by Type (2015-2020) (USD Million)
Table 180. Japan Influenza Vaccines Revenue Market Share by Type (2015-2020)
Table 181. Japan Influenza Vaccines Sales by Type (2020-2025) (K Units)
Table 182. Japan Influenza Vaccines Sales Market Share by Type (2020-2025)
Table 183. Japan Influenza Vaccines Revenue by Type (2020-2025) (USD Million)
Table 184. Japan Influenza Vaccines Revenue Market Share by Type (2020-2025)
Table 185. Global Influenza Vaccines Sales by Application (2015-2020) (K Units)
Table 186. Global Influenza Vaccines Sales Market Share by Application (2015-2020)
Table 187. Global Influenza Vaccines Revenue by Application (2015-2020) (USD Million)
Table 188. Global Influenza Vaccines Revenue Market Share by Application (2015-2020)
Table 189. Global Influenza Vaccines Price by Application (2015-2020) (USD/Unit)
Table 190. Global Influenza Vaccines Sales by Application (2020-2025) (K Units)
Table 191. Global Influenza Vaccines Sales Market Share by Application (2020-2025)
Table 192. Global Influenza Vaccines Revenue by Application (2020-2025) (USD Million)
Table 193. Global Influenza Vaccines Revenue Market Share by Application (2020-2025)
Table 194. Global Influenza Vaccines Price by Application (2020-2025) (USD/Unit)
Table 195. Japan Influenza Vaccines Sales by Application (2015-2020) (K Units)
Table 196. Japan Influenza Vaccines Sales Market Share by Application (2015-2020)
Table 197. Japan Influenza Vaccines Revenue by Application (2015-2020) (USD Million)
Table 198. Japan Influenza Vaccines Revenue Market Share by Application (2015-2020)
Table 199. Japan Influenza Vaccines Sales by Application (2020-2025) (K Units)
Table 200. Japan Influenza Vaccines Sales Market Share by Application (2020-2025)
Table 201. Japan Influenza Vaccines Revenue by Application (2020-2025) (USD Million)
Table 202. Japan Influenza Vaccines Revenue Market Share by Application (2020-2025)
Table 203. Direct Channel Pros & Cons
Table 204. Indirect Channel Pros & Cons
Table 205. Distributors/Traders/ Dealers List
Table 206. Customers of Influenza Vaccines
Table 207. Market Opportunities in Next Few Years
Table 208. Market Risks Analysis
Table 209. Market Drivers
List of Figures
Figure 1. Influenza Vaccines Picture
Figure 2. Global Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 3. Trivalent Flu Vaccines Picture
Figure 4. Quadrivalent Flu Vaccines Picture
Figure 5. Influenza Vaccines Sales Market Share by Application in 2019
Figure 6. Adults Picture
Figure 7. Pediatrics Picture
Figure 8. Global Influenza Vaccines Market Status and Outlook (2015-2025) (USD Million)
Figure 9. Global Influenza Vaccines Sales Growth Rate (2015-2025) (K Units)
Figure 10. Global Influenza Vaccines Sales Market Share by Manufacturer in 2019
Figure 11. Global Influenza Vaccines Revenue Market Share by Manufacturer in 2019
Figure 12. Key Players Influenza Vaccines Revenue Market Share in Japan in 2019
Figure 13. Global Top 5 Influenza Vaccines Manufacturer Market Share in 2019
Figure 14. Top 3 Influenza Vaccines Players Market Share in Japan in 2019
Figure 15. Global Influenza Vaccines Revenue Market Share by Regions in 2019
Figure 16. North America Influenza Vaccines Sales YoY Growth (2015-2025) (K Units)
Figure 17. North America Influenza Vaccines Revenue YoY Growth (2015-2025) (USD Million)
Figure 18. Europe Influenza Vaccines Sales YoY Growth (2015-2020) (K Units)
Figure 19. Europe Influenza Vaccines Revenue YoY Growth (2015-2020) (USD Million)
Figure 20. Asia-Pacific Influenza Vaccines Sales YoY Growth (2015-2020) (K Units)
Figure 21. Asia-Pacific Influenza Vaccines Revenue YoY Growth (2015-2020) (USD Million)
Figure 22. South America Influenza Vaccines Sales YoY Growth (2015-2020) (K Units)
Figure 23. South America Influenza Vaccines Revenue YoY Growth (2015-2020) (USD Million)
Figure 24. Middle East & Africa Influenza Vaccines Sales YoY Growth (2015-2020) (K Units)
Figure 25. Middle East & Africa Influenza Vaccines Revenue YoY Growth (2015-2020) (USD Million)
Figure 26. North America Influenza Vaccines Sales Market Share by Country in 2019
Figure 27. North America Influenza Vaccines Revenue Market Share by Country in 2019
Figure 28. United States Influenza Vaccines Market Size and Growth Rate (2015-2025) (USD Million)
Figure 29. Canada Influenza Vaccines Market Size and Growth Rate (2015-2025) (USD Million)
Figure 30. Mexico Influenza Vaccines Market Size and Growth Rate (2015-2020) (USD Million)
Figure 31. Europe Influenza Vaccines Revenue Market Share by Country in 2019
Figure 32. Germany Influenza Vaccines Market Size Growth Rate (2015-2025) (USD Million)
Figure 33. United Kingdom Influenza Vaccines Market Size Growth Rate (2015-2025) (USD Million)
Figure 34. France Influenza Vaccines Market Size Growth Rate (2015-2025) (USD Million)
Figure 35. Russia Influenza Vaccines Market Size Growth Rate (2015-2025) (USD Million)
Figure 36. Italy Influenza Vaccines Market Size Growth Rate (2015-2025) (USD Million)
Figure 37. Asia-Pacific Influenza Vaccines Sales Market Share by Region 2018
Figure 38. Asia-Pacific Influenza Vaccines Revenue Market Share by Region 2018
Figure 39. China Influenza Vaccines Market Size Growth Rate (2015-2025) (USD Million)
Figure 40. Japan Influenza Vaccines Market Size Growth Rate (2015-2025) (USD Million)
Figure 41. Korea Influenza Vaccines Market Size Growth Rate (2015-2025) (USD Million)
Figure 42. India Influenza Vaccines Market Size Growth Rate (2015-2025) (USD Million)
Figure 43. Southeast Asia Influenza Vaccines Market Size Growth Rate (2015-2025) (USD Million)
Figure 44. Australia Influenza Vaccines Market Size Growth Rate (2015-2025) (USD Million)
Figure 45. South America Influenza Vaccines Sales Market Share by Country in 2019
Figure 46. South America Influenza Vaccines Revenue Market Share by Country in 2019
Figure 47. Brazil Influenza Vaccines Market Size Growth Rate (2015-2025) (USD Million)
Figure 48. Argentina Influenza Vaccines Market Size Growth Rate (2015-2025) (USD Million)
Figure 49. Saudi Arabia Influenza Vaccines Market Size Growth Rate (2015-2025) (USD Million)
Figure 50. Turkey Influenza Vaccines Market Size Growth Rate (2015-2025) (USD Million)
Figure 51. Egypt Influenza Vaccines Market Size Growth Rate (2015-2025) (USD Million)
Figure 52. South Africa Influenza Vaccines Market Size Growth Rate (2015-2025) (USD Million)
Figure 53. Global Revenue Market Share of Influenza Vaccines by Type in 2019
Figure 54. Global Revenue Market Share of Influenza Vaccines by Application in 2019
Figure 55. Sales Channel: Direct Channel vs Indirect Channel
Companies Mentioned
AstraZeneca
FOLIA BIOTECH
Sanofi
CSL
FluGen
GlaxoSmithKline
Green Cross
BionVax
Altimmune
Genentech
SK Chemicals
Vaxart
Medicago
Visterra
UNM Pharma
Shijiazhuang Yiling Pharmaceutical
Moderna Therapeutics
Vaxine Pty
Vaccitech
Novavax
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets